Abstract P2-04-27: CTLA-4 and PD-1 checkpoint inhibitors enhance individually tailored adaptive anti-tumor immune responses to overcome tumor immunosuppression and effectively treat triple-negative breast cancer

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Hartman, ZC; Crosby, EJ; Wei, J-P; Yang, X-Y; Lei, G-J; Wang, T; Liu, C-X; Agarwal, P; Morse, MS; Lyerly, HK

Published Date

  • February 15, 2017

Published In

  • Poster Session Abstracts

Published By

Digital Object Identifier (DOI)

  • 10.1158/1538-7445.sabcs16-p2-04-27

Conference Name

  • Abstracts: 2016 San Antonio Breast Cancer Symposium; December 6-10, 2016; San Antonio, Texas